| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 1, 2004
From the Cardiovascular Research Institute and Department of Pediatrics (N.W., H.K., C.R., R.I.C.), and the Cancer Center (D.G.), University of California, San Francisco, San Francisco, Calif; the Department of Pediatrics, University of Texas Health Science Center, San Antonio, Tex (S.R.S.); the School of Women’s and Infants’ Health, University of Western Australia, Western Australia (T.J.M.M.); and the Departments of Cardiology, Pediatrics, and Physiology, Université de Montréal, Quebec, Canada (A.M.M., J.-C.F., A.V.-T., S.C.). * To whom correspondence should be addressed. E-mail: ric{at}itsa.ucsf.edu.
Background--In the preterm newborn, a patent ductus arteriosus is in large part a result of the increased sensitivity of the immature ductus to prostaglandin E2 (PGE2). PGE2 acts through 3 G protein-coupled receptors (EP2, EP3, and EP4) that activate both adenyl cyclase and KATP channels. We explored these pathways to identify the mechanisms responsible for the increased sensitivity of the immature ductus to PGE2. Methods and Results--We measured EP receptor content (mRNA and protein), receptor binding, cAMP production, and isometric tension in rings of ductus taken from immature (65% gestation) and mature (95% gestation) sheep and baboon fetuses. Ductus relaxation and cAMP generation were augmented in response to selective EP receptor agonists in the immature ductus. 8-Br-cAMP, a stable cAMP analogue, produced greater relaxation in the immature ductus. In the presence of a selective protein kinase A inhibitor, Rp-8-CPT cAMPS, the developmental differences in sensitivity to PGE2 could no longer be demonstrated. EP2, EP3, and EP4 receptor densities were higher in immature ductus, despite similar receptor mRNA and protein contents at the 2 gestational ages. In contrast, forskolin and NaF, direct activators of adenyl cyclase and Gs, respectively, elicited comparable increases in cAMP in both age groups. KATP channel inhibition also had similar effects on PGE2-induced relaxation in both age groups. Conclusions--Two mechanisms explain the increased sensitivity of the immature ductus to PGE2: (1) increased cAMP production because of increased binding of PGE2 to the individual EP receptors and (2) increased potency of cAMP on protein kinase A-regulated pathways.
Accepted on May 20, 2004
Prostaglandin E2-Mediated Relaxation of the Ductus Arteriosus. Effects of Gestational Age on G Protein-Coupled Receptor Expression, Signaling, and Vasomotor Control
Nahid Waleh PhD,
This article has been cited by other articles:
![]() |
J. Richards, A. Johnson, G. Fox, and M. Campbell A Second Course of Ibuprofen Is Effective in the Closure of a Clinically Significant PDA in ELBW Infants Pediatrics, August 1, 2009; 124(2): e287 - e293. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Greyner and E. M. Dzialowski Mechanisms mediating the oxygen-induced vasoreactivity of the ductus arteriosus in the chicken embryo Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1647 - R1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Yokoyama, S. Minamisawa, H. Quan, T. Akaike, S. Suzuki, M. Jin, Q. Jiao, M. Watanabe, K. Otsu, S. Iwasaki, et al. Prostaglandin E2-activated Epac Promotes Neointimal Formation of the Rat Ductus Arteriosus by a Process Distinct from That of cAMP-dependent Protein Kinase A J. Biol. Chem., October 17, 2008; 283(42): 28702 - 28709. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. McCurnin, S. Seidner, L.-Y. Chang, N. Waleh, M. Ikegami, J. Petershack, B. Yoder, L. Giavedoni, K. H. Albertine, M. J. Dahl, et al. Ibuprofen-Induced Patent Ductus Arteriosus Closure: Physiologic, Histologic, and Biochemical Effects on the Premature Lung Pediatrics, May 1, 2008; 121(5): 945 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Clyman, N. Waleh, H. Kajino, C. Roman, and F. Mauray Calcium-dependent and calcium-sensitizing pathways in the mature and immature ductus arteriosus Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1650 - R1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chorne, C. Leonard, R. Piecuch, and R. I. Clyman Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity Pediatrics, June 1, 2007; 119(6): 1165 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Asikainen, N. S. Waleh, B. K. Schneider, R. I. Clyman, and C. W. White Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L588 - L595. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hong, F. Hong, A. Olschewski, J. A. Cabrera, A. Varghese, D. P. Nelson, and E. K. Weir Role of Store-Operated Calcium Channels and Calcium Sensitization in Normoxic Contraction of the Ductus Arteriosus Circulation, September 26, 2006; 114(13): 1372 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Asikainen, L.-Y. Chang, J. J. Coalson, B. K. Schneider, N. S. Waleh, M. Ikegami, J. M. Shannon, V. T. Winter, P. Grubb, R. I. Clyman, et al. Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity FASEB J, August 1, 2006; 20(10): 1698 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Asikainen, B. K. Schneider, N. S. Waleh, R. I. Clyman, W.-B. Ho, L. A. Flippin, V. Gunzler, and C. W. White Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung PNAS, July 19, 2005; 102(29): 10212 - 10217. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |